Issues of further development of the healthcare sector in Kazakhstan were discussed at the regular meeting of the Council for Improvement of Investment Climate chaired by Prime Minister of Kazakhstan Alikhan Smailov, QazMonitor reports citing primeminister.kz.
The event was attended by British Ambassador to Kazakhstan Kathy Leach, Canadian Ambassador Alan Hamson, US Ambassador Daniel Rosenblum, representatives of the World Bank and Citibank for Kazakhstan, Ernst & Young, AstraZeneca, Janssen and Pfizer, heads of central government agencies of Kazakhstan.
The Prime Minister noted that the government is actively cooperating with prominent representatives of the global pharmaceutical industry, providing packages of state support measures. Plans include reaching an Investment Agreement with Pfizer on the localization of medicine production. Moreover, AstraZeneca has agreed on contract manufacturing of original pharmaceuticals with an investment volume of $32 million.
Furthermore, during President Tokayev’s visit to the US, a framework agreement was signed with GE Healthcare on the localization of medical equipment production worth $60 million.
